A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.
Some professionals stated the demand for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer laws, risking penalties, prosecution or imprisonment.
Service Reaction and Content Removal
According to the social media company, the service has removed violative content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of weight loss, positive reviews and detailed instructions for mixing or administering at home.
After moments of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A representative for Telegram stated it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has already encountered individuals injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject users to possibly significant medical dangers”.
